Mako files for $86m initial offering:
This article was originally published in Clinica
Developer of implants used in minimally-invasive knee surgery Mako Surgical is looking to raise around $86m via an initial public offering on the Nasdaq stock exchange. The company will be looking to use the proceeds of the offering to drive sales of its Makoplasty technology, which includes its robotic Haptic guidance system, implants and disposable knee surgery devices. The second-generation of the Haptic guidance system is expected to be launched in the first half of 2009, into the knee replacement and resurfacing market, which Mako claims was worth more than $2.7bn in 2006. The Fort Lauderdale, Florida-based firm expects to float under the symbol "MAKO".
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.